The overall percentage of type 2 diabetes was 38.2%, and 12 of them were newly-diagnosed as type 2 diabetes after lung cancer; 45 patients took oral medication, while 21 patients subcutaneously injected insulin, and 15 patients took both oral medication and insulin as treatment for type 2 diabetes. The gene discussed is INS; the disease is lung carcinoma.